- Home
- QIPT vs XBIT Comparison
QIPT vs XBIT Comparison
Compare QIPT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- XBIT
- Stock Information
- Founded
- QIPT 1993
- XBIT 2005
- Country
- QIPT United States
- XBIT United States
- Employees
- QIPT N/A
- XBIT N/A
- Industry
- QIPT
- XBIT Pharmaceuticals and Biotechnology
- Sector
- QIPT
- XBIT Health Care
- Exchange
- QIPT Nasdaq
- XBIT Nasdaq
- Market Cap
- QIPT 92.2M
- XBIT 105.2M
- IPO Year
- QIPT N/A
- XBIT 2015
- Fundamental
- Price
- QIPT $2.18
- XBIT $2.77
- Analyst Decision
- QIPT Strong Buy
- XBIT
- Analyst Count
- QIPT 2
- XBIT 0
- Target Price
- QIPT $6.50
- XBIT N/A
- AVG Volume (30 Days)
- QIPT 98.5K
- XBIT 60.8K
- Earning Date
- QIPT 05-12-2025
- XBIT 05-20-2025
- Dividend Yield
- QIPT N/A
- XBIT N/A
- EPS Growth
- QIPT N/A
- XBIT N/A
- EPS
- QIPT N/A
- XBIT N/A
- Revenue
- QIPT $244,723,000.00
- XBIT N/A
- Revenue This Year
- QIPT $3.35
- XBIT N/A
- Revenue Next Year
- QIPT $5.39
- XBIT N/A
- P/E Ratio
- QIPT N/A
- XBIT N/A
- Revenue Growth
- QIPT 3.82
- XBIT N/A
- 52 Week Low
- QIPT $1.86
- XBIT $2.65
- 52 Week High
- QIPT $4.17
- XBIT $9.45
- Technical
- Relative Strength Index (RSI)
- QIPT 51.50
- XBIT 41.56
- Support Level
- QIPT $2.07
- XBIT $2.71
- Resistance Level
- QIPT $2.25
- XBIT $3.08
- Average True Range (ATR)
- QIPT 0.08
- XBIT 0.22
- MACD
- QIPT 0.02
- XBIT -0.01
- Stochastic Oscillator
- QIPT 72.55
- XBIT 17.91
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.